Public Comments: August 2007 – iPledge Program / FDA ….. World Privacy Forum testifies at FDA advisory committee hearing on the iPledge program; requests attention to privacy issues
Our principal concern with iPledge is that the FDA has failed to set privacy standards for the iPledge program [2] or for similar programs that mandate patient tracking. As a result, the iPledge registry has privacy shortcomings that may potentially impact the individuals who take Accutane or Isotretinoin generics.